Progression-free survival differed significantly among arbitrarily defined endocrine sensitivity groups in metastatic #breastcancer #SABCS23
Dr. Barrios highlights how very different hormone receptor positive metastatic breast cancer can be—and compares to the Aurora trial’s validation of those definitions #SABCS23 @OncoAlertView quoted post on X